Skip to main content
. 2019 Mar 6;7(5):572–584. doi: 10.12998/wjcc.v7.i5.572

Table 3.

Main results of the pooled odds ratios in meta-analysis for the association between ADIPOQ polymorphisms and gestational diabetes mellitus

SNP N Sample size
Allelic model
Dominant model
Recessive model
Case Control OR (95%CI) P OR (95%CI) P OR (95%CI) P
+45T/G
Total 10 1024 1059 1.45 (1.26-1.67) 0.000a 1.50 (1.25-1.79) 0.000a 2.00 (1.42-2.84) 0.000a
Subgroup
Ethnicity
Asian 8 945 890 1.47 (1.27-1.70) 0.000a 1.54 (1.27-1.85) 0.000a 2.00 (1.43-2.85) 0.000a
SA 1 79 169 1.21 (0.68-2.41) 0.510 1.13 (0.59-2.15) 0.710 2.18 (0.43-11.07) 0.350
+276G/T
Total 5 590 595 0.88 (0.74-1.05) 0.158 0.91 (0.65-1.26) 0.561 0.82 (0.64-1.05) 0.118
-11377C/G
Total 5 722 791 0.96 (0.72-1.26) 0.750 1.00 (0.73-1.37) 0.980 0.90 (0.61-1.32) 0.570
Subgroup
Ethnicity
Asian 2 309 286 1.04 (0.77-1.41) 0.800 1.09 (0.79-1.50) 0.600 0.97 (0.51-1.86) 0.930
SA 1 79 168 0.80 (0.50-1.29) 0.360 0.77 (0.44-1.36) 0.370 0.81 (0.28-2.34) 0.690
European 2 334 337 0.94 (0.45-1.96) 0.870 1.00 (0.42-2.33) 0.990 0.87 (0.51-1.49) 0.610
a

P < 0.01. ADIPOQ: Adiponectin; SA: South American; GDM: Gestational diabetes mellitus; SNP: Single nucleotide polymorphism; N: Number of studies; OR: Odds ratio; CI: Confidence interval; NA: Not assessable.